Streamline Health Solutions, Inc. (STRM): Company Projected Revenue

Brandmark of Streamline Health Solutions (STRM)

High barriers to entry due to software integration in US hospitals ensure the stability of Streamline Health Solutions (STRM). The company's sales volume forecast reflects a trend where this metric equals 0.02. Growth is supported by SaaS subscriptions for revenue management, which create a predictable cash flow. Technological leadership is solidified through the implementation of AI algorithms into the eREVENUE billing automation system.

STRM - Streamline Health Solutions Company Future Sales over the range 07/04/2022 - 08/24/2025

Summary analytical data breakdowns for Streamline Health Solutions, Inc. (STRM)

- stock value and consensus price forecast:
Fundamental valuation:Streamline Health Solutions
Brand item of Streamline Health, Inc.

Assessing the financial stability of Streamline Health Solutions (STRM) requires an analysis of its market expansion potential. This indicator translates long-term revenue forecasts into daily price action, measuring the expected intensity of commercial flow. By analyzing the company's planned sales figures, an investor determines the pace of business scaling relative to competitors. For Streamline Health Solutions, this is a critical marker of efficiency in transitioning to a cloud subscription model. Growth in this metric would confirm the company's ability to withstand software behemoths.

Direct competitors

Company Projected Revenue Veeva Systems Inc. (VEEV)|Company Future Sales Volume doximity.com DOCS|Company Projected Revenue HealthEquity HQY|Waystar Health - Company Projected Revenue|CorVel Healthcare - Projected Sales Volume|Company Future Sales Privia Medical Group PRVA|Huron Consulting Group (HURN) - Company Projected Revenue|Company Revenue Forecast CERT|OMCL (Omnicell) - Projected Sales Volume|Company Expected Sales Volume GoodRx Inc GDRX|Company Future Sales Volume SDGR (Schrödinger Inc.)|PHR (Phreesia Health) - Company Future Revenue|Projected Sales Volume OMDA (Omada Health Inc)|Company Future Revenue EVH|HealthStream - Projected Sales Volume|Company Expected Sales Volume Definitive Healthcare Corp|CCSI: Projected Sales Volume|Agilon Health Corp (AGL) - Projected Sales Volume|Company Projected Revenue Absci|Company Projected Revenue SY|Company Future Sales Volume NRC (nrchealth.com)|Company Projected Revenue Volume SPOK|Projected Sales Volume OPRX (OptimizeRx Corp.)|Company Future Revenue TBRG|SLP: Company Future Sales Volume|Company Future Revenue SOPH (SOPHiA GENETICS SA)|Health Catalyst (HCAT) - Company Projected Revenue|CCLD - Company Future Sales|Company Projected Revenue Research Solutions, Inc.|Company Expected Sales Volume DLH Holdings Corp DLHC|Company Projected Revenue OneMedNet Corporation (ONMD)|Company Projected Revenue SCNX (scienture.com)|Healthcare Triangle, Inc. - Company Future Sales Volume|Projected Sales Volume iSpecimen Inc ISPC|BFRG: Company Future Sales Volume|SCWorx Inc - Company Projected Revenue Volume|MSPR: Projected Sales Volume|ICCT - Company Future Sales|Company Projected Revenue TRxADE HEALTH|Company Expected Sales Volume Orgenesis Inc ORGS|Company Projected Revenue R1 RCM Inc. (RCM)|Sharecare Inc - Company Revenue Forecast|Company Projected Revenue Syra Health Corp. SYRA|Company Future Sales Apollo Medical Holdings Inc. (AMEH)|MODN - Company Projected Revenue|Company Future Sales NextGen Healthcare Inc NXGN